A was associated with greater depressive symptoms (left parietal cortex) and poorer visual-spatial memory (left temporal cortex) before treatment, but was not correlated with improvement with citalopram treatment [338]
This session addresses the following ACGME Competencies: Medical Knowledge, Systems-based Practice This session addresses the following ICPE Competencies:Values and Ethics, Roles and Responsibilities Learning Objectives Upon completion, learners will be able to: describe the preclinical evidence in favor of repurposing GLP-1 receptor agonists as possible addiction pharmacotherapies recount the clinical trials studying the safety and efficacy of GLP-1 receptor agonists for addiction consider methods for providing fair and just access to new, expensive medications like GLP-1 receptor agonists to all segments of society Registration Rates *Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate
It reduces sympathetic activity
Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, Pattison JS, et al
To conduct the study, researchers did the following: Analyzed the records of more than 17,000 patients over six years after Ozempic was released (2017-2023)
Ethics statement The studies involving human participants were reviewed and approved by Beth Israel Deaconess Medical Center Institutional Review Board
